Mustang Bio logo

Mustang Bio

MBIO | NASDAQ
Chart Builder DCF Calculator
$0.48
-$0.03 (-5.31%)
At close: Sep 29, 2026, 4:00 PM ET
-5.31%

Rating

Updated: Sep 19, 2026
21.2
Fundamentals Weak
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $3.63M
1D Range
0.47 0.51
52W Range
0.47 1.85

Valuation (TTM)

PE -1.07
PB 0.48
EV/EBITDA 3.80

Valuation (NTM)

Forward PE N/A
Forward PEG -0.00
Price Target N/A
Loading financial charts...

Profile

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company...

Sector Healthcare
Industry Biotechnology
Employees 4
IPO Date Aug 22, 2017
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.